Understand disease biology from organ to molecule - faster

Explore disease biology in cellular detail

The Euretos Disease Atlas maps diseases and their molecular interactions across organs, tissues, and cell types — helping you discover mechanisms, drivers, and therapeutic targets in one interactive view.

From fragmented evidence to unified insight

The Euretos Disease Atlas transforms scattered biomedical data into coherent insight, unifying thousands of datasets and millions of publications within one explainable framework

Essential capabilities for translational researchers

The Euretos Disease Atlas equips researchers with integrated tools to investigate disease biology across molecular, cellular, and anatomical levels—linking mechanisms, targets, and metabolic pathways through transparent, evidence-based analysis.

Pathophysiological insight

Understand all levels of disease biology

Anatomical navigation

Explore 30.000+ diseases across 3.500 cell types

Disease drivers

Identify core regulatory genes and pathways.

Target assessment

Evaluate efficacy, tractability, and safety.

Metabolite view

Analyze metabolic interactions and biomarkers.

Explainable scoring

Transparent evidence for every result.

Proven reliability for over a decade

Trusted by leading academic organisations, pharma and biotech for disease research and target discovery.
SVG Graphic

Make better target decisions — faster.

A single dashboard for translational, biology & safety teams
From datasets to high confidence target shortlist in days
Explainable scores backed by FAIR data
Investigate disease biology across all molecular and anatomical levels

 
tevalogo
"I find the Euretos platform to be valuable in what it offers in terms of advanced AI capabilities and analytics of smart scouting and literature searches to probe relevant targets, indications, and therapeutics. The professional support and dedicated mentoring from experienced bioinformatics professionals that Euretos offers greatly enhances our ability to take advantage of all the capabilities of the platform, and extract meaningful insights for our day-to-day mission of bringing innovation into Teva."
 
Dr. Dana Bar-On - Sr. Director, Head of Academic Affairs and Networks, Specialty R&D, Teva  Pharmaceuticals. 
 

Build detailed insights into the pathophysiology of disease

Explore how molecular, cellular and anatomical factors shape disease processes to generate and refine hypotheses grounded in full biological context
SVG Graphic

Build detailed insights into the pathophysiology of disease

Explore how molecular, cellular and anatomical factors shape disease processes to generate and refine hypotheses grounded in full biological context
SVG illustration
Get Started
SVG Graphic

Identify and prioritize novel therapeutic targets

Discover biologically relevant targets by evaluating expression patterns, pathway roles, and interactions within disease-specific tissues and cell types.

Identify and prioritize novel therapeutic targets

Discover biologically relevant targets by evaluating expression patterns, pathway roles, and interactions within disease-specific tissues and cell types.
SVG Graphic
Contact Us

Evaluate target relevance and actionability

Review key characteristics of candidate targets — gene variants, dysregulation, druggability, and clinical associations — linked to their anatomical context and relevant disease drivers
SVG Graphic

Evaluate target relevance and actionability

Review key characteristics of candidate targets — gene variants, dysregulation, druggability, and clinical associations — linked to their anatomical context and relevant disease drivers
SVG illustration
Get Started
SVG Graphic

Discover markers linked to disease mechanisms

Discover molecular markers associated with key disease drivers by analyzing expression patterns, variants, dysregulation, and their bioavailability and metabolic interactions across relevant cell types and anatomical contexts

Discover markers linked to disease mechanisms

Discover molecular markers associated with key disease drivers by analyzing expression patterns, variants, dysregulation, and their bioavailability and metabolic interactions across relevant cell types and anatomical contexts
SVG Graphic
Contact Us

Rapidly create thorough, evidence-backed scientific briefs

Easily find well-organized information supported by publications and data on genes, diseases, mechanisms and treatments to support clear and reliable scientific communication
SVG Graphic

Rapidly create thorough, evidence-backed scientific briefs

Easily find well-organized information supported by publications and data on genes, diseases, mechanisms and treatments to support clear and reliable scientific communication
SVG illustration
Get Started
Client review

Target Discovery

"We worked with Euretos to leverage their AI capabilities with the aim of finding new targets in two different indications. It was a real pleasure to work with them and the whole process was characterized by transparency, their willingness to listen to our needs and suggestions, and swift responses and data delivery. In addition, we found their platform very useful for getting an overview of the different targets and for general queries."

Tau Benned-Jensen
Senior Research Scientist, H. Lundbeck A/S
Client review

Indication selection

“In this project, we evaluated you against our internal investigations and the results of one other external provider. What really sets you apart is how you combine a fundamentally biological and data-driven approach. The breadth of the indications you assess and the depth of your analysis sets you apart and is a clear value add to our internal capabilities.”

Large European Pharma
Global Head
Client review

Target Assessment

"I find the Euretos platform to be valuable in what it offers in terms of advanced AI capabilities and analytics of smart scouting and literature searches to probe relevant targets, indications, and therapeutics. The professional support and dedicated mentoring from experienced bioinformatics professionals that Euretos offers greatly enhances our ability to take advantage of all the capabilities of the platform, and extract meaningful insights for our day-to-day mission of bringing innovation into Teva."

Dr. Dana Bar-On
Sr. Director, Head of Academic Affairs and Networks, Specialty R&D, Teva Pharmaceuticals
Client review

Target Discovery

"We have been working with Euretos for many years now. They provide us with unique tools that we use as an integral part of our target discovery and validation. Using the Euretos AI platform is a mandatory input to our target discovery meetings."

Large European Biotech
Director Target Discovery
Client review

Indication Selection

"We find that the Euretos group was very easy to work and communicate with. The professional staff at Euretos did a great job extending their platform and capabilities to our advantage. Euretos helped us to extract meaningful information from a highly complex data domain, that we could build on internally."

Henriette Husum Bak-Jensen
Project Manager, Projects & Portfolio department, H. Lundbeck A/S
Client review

Target Assessment

"We are fascinated by the suggested hypothesis. It was great that even very small expressional changes were captured and a hypothesis was generated. The interpretation was also convincing and consistent. Also, the team is well engaged, and had a very good understanding in the background of the project and our research question"

Large Japanese Pharma
Principal Scientist

Data-driven disease insights